These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11230850)

  • 1. Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2.
    Angeja BG; Rundle AC; Gurwitz JH; Gore JM; Barron HV
    Am J Cardiol; 2001 Mar; 87(5):627-30, A9. PubMed ID: 11230850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
    Gurwitz JH; Gore JM; Goldberg RJ; Barron HV; Breen T; Rundle AC; Sloan MA; French W; Rogers WJ
    Ann Intern Med; 1998 Oct; 129(8):597-604. PubMed ID: 9786806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction).
    Goldberg RJ; Mooradd M; Gurwitz JH; Rogers WJ; French WJ; Barron HV; Gore JM
    Am J Cardiol; 1998 Aug; 82(3):259-64. PubMed ID: 9708650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of reteplase with alteplase for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
    N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
    Am J Cardiol; 1995 May; 75(15):987-92. PubMed ID: 7747700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment.
    Carlson SE; Aldrich MS; Greenberg HS; Topol EJ
    Arch Neurol; 1988 Oct; 45(10):1070-3. PubMed ID: 3140769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
    Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
    Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2).
    Peterson LR; Chandra NC; French WJ; Rogers WJ; Weaver WD; Tiefenbrunn AJ
    Am J Cardiol; 1999 Dec; 84(11):1287-91. PubMed ID: 10614792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autopsy case of intracranial hemorrhage during tissue plasminogen activator infusion.
    Masuoka H; Kotani H; Yazu T; Mizuno O; Miyahara M; Sekoguchi K; Tanaka R; Ueda K; Fukui A; Futagami Y
    Heart Vessels; 1993; 8(3):163-5. PubMed ID: 8407727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
    Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
    Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genentech experience with rt-PA (activase).
    Grossbard EB
    J Am Coll Cardiol; 1987 Feb; 9(2):467. PubMed ID: 3100603
    [No Abstract]   [Full Text] [Related]  

  • 15. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community hospital experience with recombinant tissue plasminogen activator in acute myocardial infarction.
    Austin SM; Caro M; Gemmel D
    J Gen Intern Med; 1992; 7(2):187-90. PubMed ID: 1487767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis.
    Hiatt MD
    Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator should not be used in acute ischemic stroke.
    Riggs JE
    Arch Fam Med; 1997; 6(2):102-4. PubMed ID: 9075439
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment.
    Pendlebury WW; Iole ED; Tracy RP; Dill BA
    Ann Neurol; 1991 Feb; 29(2):210-3. PubMed ID: 1901466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.